A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small cell lung cancer.

S Tsuchiya; K Minato; H Nakano; A Takise; K Ezawa; N Fueki; H Hoshino; I Naruse; Y Takei; T Makimoto

doi:10.1159/000227466

A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small cell lung cancer.

Identifier:nobleid.org/w1/20260515/CD5D43CC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD5D43CC.svg?ark=w1%2F20260515%2FCD5D43CC)](https://nobleid.org/work/w1/20260515/CD5D43CC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small cell lung cancer.

Identifier:nobleid.org/w1/20260515/CD5D43CC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD5D43CC.svg?ark=w1%2F20260515%2FCD5D43CC)](https://nobleid.org/work/w1/20260515/CD5D43CC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work